Michael Chuong/mapquest.com
Oct 7, 2024, 18:32
Michael Chuong: 5-fx SMART vs 15/25-fx HART outcomes at ASTRO24
Michael Chuong shared a post on LinkedIn:
“Thanks to American Society for Radiation Oncology (ASTRO) for the invitation to share our 5-fx SMART vs 15/25-fx HART outcomes at ASTRO24.
- 211 locally advanced pancreatic cancer patients from Baptist Health Miami Cancer Institute and Memorial Sloan Kettering Cancer Center
- Ablative dose: BED10 ~100 Gy
- 2-yr LC/OS, Gr3+ tox favorable
- Online adaptive radiation therapy may offer significant benefits
- Please support our upcoming phase 3 NRG GI011 trial!”
Source: Michael Chuong/LinkedIn
More posts featuring Michael Chuong.
Michael Chuong is the GI Section Editor for the International Journal of Radiation Oncology Biology Physics. He is a Professor at Florida International University’s Herbert Wertheim College of Medicine and serves as the Vice Chair and Medical Director of the Department of Radiation Oncology at the Miami Cancer Institute.
Additionally, he is the Chief of the GI Radiation Oncology Service at Baptist Health South Florida, specializing in the treatment of gastrointestinal cancers.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 09:06
Dec 21, 2024, 09:00
Dec 21, 2024, 08:51
Dec 21, 2024, 08:48
Dec 21, 2024, 08:42
Dec 21, 2024, 08:37
Dec 21, 2024, 08:29
Dec 21, 2024, 08:12
Dec 21, 2024, 07:45